NeoGenomics Inc (NEO)
- Exchange
- NASDAQ
- Symbol
- NEO
- Sector
- Trade & Services
- Industry
- Services-testing Laboratories
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
- Country
- USA
Stock price
At close: November 6, 2024
-
Open15.68
-
High15.80
-
Low14.87
-
Close15.46
-
Volume1,245,880
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
29.32
Receivables turnover
4.58
Payables turnover
34.83
Working capital turnover
1.20
Days of inventory on hand (DOH)
12.45
Days of sales outstanding (DSO)
79.61
Number of days of payables
10.48
Fixed asset turnover
6.54
Total asset turnover
0.36
Current ratio
6.20
Quick ratio
5.67
Cash ratio
4.31
Cash conversion cycle
81.58
Debt-to-assets ratio
0.32
Debt-to-capital ratio
0.36
Debt-to-equity ratio
0.57
Financial leverage ratio
1.79
Interest coverage
-13.06
Gross profit margin
40.66%
Operating profit margin
-17.91%
Pretax margin
-16.14%
Net profit margin
-14.62%
Operating return on assets (Operating ROA)
-6.41%
Return on assets (ROA)
-5.23%
Return on total capital
-6.10%
Return on equity (ROE)
-9.34%